Allison B. Goldfine

The cellular fate of glucose and its relevance in type 2 diabetes.

A. Goldfine, C. Kahn, C. Bouché, 2004, Endocrine reviews.

Diabetes primes neutrophils to undergo NETosis, which impairs wound healing

C. Kahn, A. Goldfine, D. Wagner, 2015, Nature Medicine.

Comparative cardiovascular safety of glucagon‐like peptide‐1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study

R. Glynn, A. Goldfine, B. Everett, 2016, Diabetes, obesity & metabolism.

Adiponectin: linking the fat cell to insulin sensitivity

A. Goldfine, C. Kahn, Allison B. Goldfine, 2003, The Lancet.

Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy

Chintan V. Dave, Allison B. Goldfine, Robert J. Glynn, 2021 .